BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 12470949)

  • 1. Insights into substrate binding and catalytic mechanism of human tyrosyl-DNA phosphodiesterase (Tdp1) from vanadate and tungstate-inhibited structures.
    Davies DR; Interthal H; Champoux JJ; Hol WG
    J Mol Biol; 2002 Dec; 324(5):917-32. PubMed ID: 12470949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The crystal structure of human tyrosyl-DNA phosphodiesterase, Tdp1.
    Davies DR; Interthal H; Champoux JJ; Hol WG
    Structure; 2002 Feb; 10(2):237-48. PubMed ID: 11839309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of a transition state mimic for Tdp1 assembled from vanadate, DNA, and a topoisomerase I-derived peptide.
    Davies DR; Interthal H; Champoux JJ; Hol WG
    Chem Biol; 2003 Feb; 10(2):139-47. PubMed ID: 12618186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Explorations of peptide and oligonucleotide binding sites of tyrosyl-DNA phosphodiesterase using vanadate complexes.
    Davies DR; Interthal H; Champoux JJ; Hol WG
    J Med Chem; 2004 Feb; 47(4):829-37. PubMed ID: 14761185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Theoretical Study of Phosphoryl Transfers of Tyrosyl-DNA Phosphodiesterase I (Tdp1) and the Possibility of a "Dead-End" Phosphohistidine Intermediate.
    DeYonker NJ; Webster CE
    Biochemistry; 2015 Jul; 54(27):4236-47. PubMed ID: 26121557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Tdp1 cleaves a broad spectrum of substrates, including phosphoamide linkages.
    Interthal H; Chen HJ; Champoux JJ
    J Biol Chem; 2005 Oct; 280(43):36518-28. PubMed ID: 16141202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC 88915) and related novel steroid derivatives as tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors.
    Dexheimer TS; Gediya LK; Stephen AG; Weidlich I; Antony S; Marchand C; Interthal H; Nicklaus M; Fisher RJ; Njar VC; Pommier Y
    J Med Chem; 2009 Nov; 52(22):7122-31. PubMed ID: 19883083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate specificity of tyrosyl-DNA phosphodiesterase I (Tdp1).
    Raymond AC; Staker BL; Burgin AB
    J Biol Chem; 2005 Jun; 280(23):22029-35. PubMed ID: 15811850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-function studies of a plant tyrosyl-DNA phosphodiesterase provide novel insights into DNA repair mechanisms of Arabidopsis thaliana.
    Kim H; Na SH; Lee SY; Jeong YM; Hwang HJ; Hur JY; Park SH; Woo JC; Kim SG
    Biochem J; 2012 Apr; 443(1):49-56. PubMed ID: 22214184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosyl-DNA phosphodiesterase (Tdp1) (3'-phosphotyrosyl DNA phosphodiesterase).
    Raymond AC; Burgin AB
    Methods Enzymol; 2006; 409():511-24. PubMed ID: 16793421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosyl-DNA phosphodiesterase 1 initiates repair of apurinic/apyrimidinic sites.
    Lebedeva NA; Rechkunova NI; El-Khamisy SF; Lavrik OI
    Biochimie; 2012 Aug; 94(8):1749-53. PubMed ID: 22522093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel high-throughput electrochemiluminescent assay for identification of human tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors and characterization of furamidine (NSC 305831) as an inhibitor of Tdp1.
    Antony S; Marchand C; Stephen AG; Thibaut L; Agama KK; Fisher RJ; Pommier Y
    Nucleic Acids Res; 2007; 35(13):4474-84. PubMed ID: 17576665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Class of Tyrosyl-DNA Phosphodiesterase 1 Inhibitors That Contains the Octahydro-2
    Li-Zhulanov NS; Zakharenko AL; Chepanova AA; Patel J; Zafar A; Volcho KP; Salakhutdinov NF; Reynisson J; Leung IKH; Lavrik OI
    Molecules; 2018 Sep; 23(10):. PubMed ID: 30261631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosyl-DNA phosphodiesterase I resolves both naturally and chemically induced DNA adducts and its potential as a therapeutic target.
    Comeaux EQ; van Waardenburg RC
    Drug Metab Rev; 2014 Nov; 46(4):494-507. PubMed ID: 25327705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-steady state kinetics of DNA binding and abasic site hydrolysis by tyrosyl-DNA phosphodiesterase 1.
    Kuznetsov NA; Lebedeva NA; Kuznetsova AA; Rechkunova NI; Dyrkheeva NS; Kupryushkin MS; Stetsenko DA; Pyshnyi DV; Fedorova OS; Lavrik OI
    J Biomol Struct Dyn; 2017 Aug; 35(11):2314-2327. PubMed ID: 27687298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a ligand binding hot spot and structural motifs replicating aspects of tyrosyl-DNA phosphodiesterase I (TDP1) phosphoryl recognition by crystallographic fragment cocktail screening.
    Lountos GT; Zhao XZ; Kiselev E; Tropea JE; Needle D; Pommier Y; Burke TR; Waugh DS
    Nucleic Acids Res; 2019 Nov; 47(19):10134-10150. PubMed ID: 31199869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The First Berberine-Based Inhibitors of Tyrosyl-DNA Phosphodiesterase 1 (Tdp1), an Important DNA Repair Enzyme.
    Gladkova ED; Nechepurenko IV; Bredikhin RA; Chepanova AA; Zakharenko AL; Luzina OA; Ilina ES; Dyrkheeva NS; Mamontova EM; Anarbaev RO; Reynisson J; Volcho KP; Salakhutdinov NF; Lavrik OI
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosyl-DNA Phosphodiesterase 1 (Tdp1) inhibitors.
    Huang SN; Pommier Y; Marchand C
    Expert Opin Ther Pat; 2011 Sep; 21(9):1285-92. PubMed ID: 21843105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of phosphotyrosine mimetic inhibitors of human tyrosyl-DNA phosphodiesterase I by a novel AlphaScreen high-throughput assay.
    Marchand C; Lea WA; Jadhav A; Dexheimer TS; Austin CP; Inglese J; Pommier Y; Simeonov A
    Mol Cancer Ther; 2009 Jan; 8(1):240-8. PubMed ID: 19139134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents.
    Zhang XR; Wang HW; Tang WL; Zhang Y; Yang H; Hu DX; Ravji A; Marchand C; Kiselev E; Ofori-Atta K; Agama K; Pommier Y; An LK
    J Med Chem; 2018 Nov; 61(22):9908-9930. PubMed ID: 30336023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.